157 related articles for article (PubMed ID: 29225246)
21. Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.
Bennouna J; Senellart H; Hiret S; Vaissiere N; Douillard JY
Lung Cancer; 2011 Oct; 74(1):30-4. PubMed ID: 21371774
[TBL] [Abstract][Full Text] [Related]
22. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer.
De Pas T; Raimondi S; Pelosi G; Spaggiari L; De Braud F; Veronesi G; Maisonneuve P
Acta Oncol; 2010 May; 49(4):480-4. PubMed ID: 20105088
[TBL] [Abstract][Full Text] [Related]
23. Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: a case report of long-term survival.
Yokoi K; Miyazawa N
Eur J Cardiothorac Surg; 1996; 10(2):141-3. PubMed ID: 8664005
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
Feld R; Rubinstein L; Thomas PA
Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Higuchi M; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Hasegawa T; Suzuki H
World J Surg Oncol; 2016 Sep; 14(1):238. PubMed ID: 27595749
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
[TBL] [Abstract][Full Text] [Related]
27. Use of adjuvant chemotherapy in non-small cell lung cancer in routine practice.
Massard C; Tran Ba Loc P; Haddad V; Pignon JP; Girard P; Monnet I; Trédaniel J; Besse B; Soria JC
J Thorac Oncol; 2009 Dec; 4(12):1504-10. PubMed ID: 19745763
[TBL] [Abstract][Full Text] [Related]
28. Bevacizumab-induced Aortic Arterial Thrombosis.
Suzuki K; Yanagimura T; Ohashi K; Kagamu H; Takada T
Intern Med; 2018 Oct; 57(20):2987-2990. PubMed ID: 29780110
[TBL] [Abstract][Full Text] [Related]
29. A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial.
Gao LL; Huang XE; Zhang Q; Tang JH
Asian Pac J Cancer Prev; 2011; 12(1):77-80. PubMed ID: 21517235
[TBL] [Abstract][Full Text] [Related]
30. Acute arterial thrombosis in a patient with small cell lung cancer after a cycle of chemotherapy with cisplatin and etoposide.
Longo F; Mansueto G; Poggi A; Pellegrini P; Falzetta A; Rozzi A; Marchei P
Tumori; 1999; 85(3):214-5. PubMed ID: 10426136
[No Abstract] [Full Text] [Related]
31. Acute multiple arterial thrombosis after cisplatin in base of tongue carcinoma: case report.
Rishi A; Ghoshal S
Head Neck; 2013 Sep; 35(9):E269-71. PubMed ID: 22915348
[TBL] [Abstract][Full Text] [Related]
32. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
Douillard JY; Tribodet H; Aubert D; Shepherd FA; Rosell R; Ding K; Veillard AS; Seymour L; Le Chevalier T; Spiro S; Stephens R; Pignon JP;
J Thorac Oncol; 2010 Feb; 5(2):220-8. PubMed ID: 20027124
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival after salvage surgery for colorectal lung metastases.
Presicci PF; Veronesi G; D'Aiuto M; Spaggiari L
Ann Thorac Surg; 2005 Jan; 79(1):325-6. PubMed ID: 15620970
[TBL] [Abstract][Full Text] [Related]
35. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
Torre W; Sierra A
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
[TBL] [Abstract][Full Text] [Related]
36. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group.
Ohta M; Tsuchiya R; Shimoyama M; Sawamura K; Mori T; Miyazawa N; Suemasu K; Watanabe Y; Tomita M; Terashima M
J Thorac Cardiovasc Surg; 1993 Oct; 106(4):703-8. PubMed ID: 8412266
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
Heon S; Johnson BE
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin-based adjuvant chemotherapy in resected non-small-cell lung cancer.
Gibson AD
Clin Lung Cancer; 2003 Jul; 5(1):18-20. PubMed ID: 14596698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
